Both in Biotechnology
Alector vs Protalix BioTherapeutics
Over the past year ALEC returned −38.7% and PLX returned +24.5%; their daily moves had a correlation of 0.15.
ALEC −38.7% PLX +24.5%Growth of $1, one year, split-adjusted
| Metric | ALEC | PLX |
|---|---|---|
| Price | $1.87 | $2.69 |
| Market cap | $208.8M | $216.7M |
| Today | −2.60% | 0.00% |
| 1 month | −20.1% | +5.9% |
| 6 months | −7.4% | +28.7% |
| Year to date | +19.9% | +49.4% |
| 1 year | −39.7% | +30.6% |
| Revenue growth (YoY) | −57.8% | +27.1% |
| Gross margin | 100.0% | 61.0% |
| Net margin | −692.5% | 19.0% |
| P/E (TTM) | — | 11.4× |
| Price / sales | 15.1× | 2.7× |
| Net cash | $162.9M | $40.7M |
| Dividend yield | — | — |
| Volatility (60d) | 99.1% | 43.8% |
| Short % of float | 6.6% | 3.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).